Brief: Scilex Holding A Majority-Owned Subsidiary Of Sorrento Therapeutics Enters Into A Non-Binding Term Sheet

Sorrento Therapeutics

25/03/2022 13:16

March 25 (Reuters) - Sorrento Therapeutics Inc  SRNE.O :
    * SCILEX HOLDING COMPANY, A MAJORITY-OWNED SUBSIDIARY OF
SORRENTO
THERAPEUTICS, INC., ENTERS INTO A NON-BINDING TERM SHEET FOR A
$5 BILLION COMMITTED EQUITY FINANCING FACILITY TO BE EFFECTIVE
IN CONNECTION WITH THE CLOSING OF THE MERGER WITH VICKERS
VANTAGE CORP I
    * SCILEX HOLDING COMPANY, A MAJORITY-OWNED SUBSIDIARY OF
SORRENTO
THERAPEUTICS, INC., ENTERS INTO A NON-BINDING TERM SHEET
    * SCILEX HOLDING COMPANY - WOULD NOT BE OBLIGATED TO UTILIZE
ANY
OF $5 BILLION FACILITY AND WOULD BE ABLE TO ENTER OTHER
FINANCING TRANSACTIONS
    * SCILEX HOLDING COMPANY - NO WARRANTS WILL BE ISSUED IN
CONNECTION WITH FACILITY
    * SCILEX HOLDING - ENTERS INTO NON-BINDING TERM SHEET FOR A
$5
BILLION COMMITTED EQUITY FINANCING FACILITY TO BE EFFECTIVE IN
CONNECTION WITH DEAL CLOSING

Source text for Eikon:  ID:nGNX8Tz1HG 
Further company coverage:  SRNE.O 

 ((Reuters.Briefs@thomsonreuters.com;))